立力科阿克赛诺（北京）医药研发咨询有限公司

公司简介

立力科阿克赛诺（北京）医药研发咨询有限公司，前身为北京阿克赛诺医药研发咨询有限公司，为美国阿克赛诺公司（总部在美国马里兰州的CRO）在中国的全资子公司，于2005年6月在中国北京朝阳区注册成立并开始运营。由于业务发展的需要，2018年7月26日，美国阿克赛诺有限公司与Linical Co.,Ltd.合并成为其中的一部分。Linical Co.,Ltd.是一家总部设立在日本的CRO, 是肿瘤学、免疫学和神经学领域的专家。Linical Accelovance China Ltd., formerly known as Accelovance (China) Co., Ltd., is a wholly owned subsidiary of Accelovance Inc. (a CRO, headquartered in Maryland, USA) in China. It was registered and started operation in Chaoyang district, Beijing, China in June 2005. Due to the need of business development, on July 26, 2018, Accelovance American Ltd. merged with Linical Co., Ltd. and is now a subsidiary of Linical. Linical Co., Ltd., is a japanese-based CRO, is an expert in oncology, immunology and neurology.公司主营医药研发的咨询和服务业务包括：临床法规服务、临床试验管理（包括项目管理、监查）、药物警戒。The company's main pharmaceutical research and development consulting and service business includes: clinical regulatory services, clinical trial management (including project management, monitor), and pharmacovigilance.公司秉承客户至上、质量***、对客户、医生、病人、员工及对社会健康事业充分负责的态度提供对相关领域的专业服务。The company adheres to the attitude of customer first, quality first, full responsibility for customers, doctors, patients, employees and social health undertakings to provide professional services in related fields.为达到这一目的，公司聘用优秀的专业人才，注重对员工的培训，注重员工个人发展，注重在公司内部建设和谐、平等、发展的文化氛围。In order to achieve this goal, the company employs excellent professionals, pays attention to the training of employees, pays attention to the personal development of employees, and pays attention to the construction of a harmonious, equal and developing cultural atmosphere within the company.